Skip to main content
Top

16-03-2016 | Pregnancy | Review | Article

Management of Pregnant Women with Type 2 Diabetes Mellitus and the Consequences of Fetal Programming in Their Offspring

Journal: Current Diabetes Reports

Authors: Diane C. Berry, Kim Boggess, Quinetta B. Johnson

Publisher: Springer US

Abstract

The obesity epidemic has fueled an epidemic of prediabetes and type 2 diabetes mellitus in women of childbearing age. This paper examines the state of the science on preconception and pregnancy management of women with type 2 diabetes to optimize outcomes for the women and their infants. In addition, the consequence of fetal programming as a result of suboptimal maternal glycemic control is discussed. The paper focuses on type 2 diabetes, not type 1 diabetes or gestational diabetes. Management of women with type 2 diabetes includes preconception counseling, preconception weight management and weight loss, proper weight gain during pregnancy, self-monitoring of blood glucose levels, medication, medical nutrition therapy, and exercise.
Literature
1.•
American Diabetes Association. Standards of medical care in diabetes—2015. Diabetes Care. 2015;38 Suppl 1:S1–92. This reference gives an excellent overview of diabetes self-management.
2.••
American Diabetes Association, Medical management of pregnancy complicated by diabetes. 5th ed, ed. D.R. Coustan. 2013; Alexandria: American Diabetes Association. This reference gives an excellent overview of diabetes self-management in pregnant women.
3.••
Guariguata L et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103:137–49. This reference gives projections for the future epidemic of diabetes globally.
4.
International Diabetes Federation. IDF diabetes atlas—2015. 7th ed. Brussels: International Diabetes Federation; 2015.
5.
Castorino K, Jovamovic L. Pregnancy and diabetes management: advances and controversies. Clin Chem. 2011;57(2):221–30.CrossRefPubMed
6.
Yajnik CS. Fetal programming of diabetes: still so much to learn! Diabetes Care. 2010;33(5):1146–8.CrossRefPubMedPubMedCentral
7.••
Portha B, Chavey A, Movassat J. Early-life origins of type 2 diabetes: fetal programming of the beta-cell mass. Exp Diabetes Res. 2011;2011:1–14. Excellent reference on fetal programming.
8.
Physicians’ desk reference. 70th ed. Montvale, NJ: PDR, LLC; 2016: 2084-2093.
9.
U.S. Department of Health and Human Services. Aim for a healthy weight. Bethesda, MD: U.S. Department of Health and Human Services; 2010. NIH Publication No. 10-7415.
10.
Institute of Medicine. Weight gain during pregnancy: reexamining the guidelines. Washington, DC: National Academies Press; 2009.
11.••
American Diabetes Association. Management of diabetes in pregnancy: standards of medical care in diabetes—2015. Diabetes Care. 2015;38 Suppl 1:S77–9. Excellent reference on management of diabetes in pregnancy.CrossRef
12.
Gallen IW, Jaap A, Roland JM, Chirayath HH. Survey of glargine use in 115 pregnant women with type 1 diabetes mellitus. Diabet Med. 2008;25:165–9.CrossRefPubMed
13.
Imbergamo MP, Amato MC, Sciortino G, Gambina M, Accidenti M, Criscimanna A, et al. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study. Clin Ther. 2008;38:1476–89.CrossRef
14.
Kurtzhals P et al. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes Care. 2000;49:999–1005.CrossRef
15.
Jovanovic L, Druzin M, Peterson C. Effect of euglycemia on the outcome of pregnancy in insulin dependent diabetic women as compared with normal control subjects. Am J Med. 1981;71:921–7.CrossRefPubMed
16.
Goh JE, Sadler L, Rowan J. Metformin for gestational diabetes in routine clinical practice. Diabetes Med. 2011;28(9):1082–7.CrossRef
17.
Mukherjee MS, Coppenrath VA, Dallinga BA. Pharmacologic management of types 1 and 2 diabetes mellitus and their complications in women of childbearing age. Pharmacotherapy. 2015;35(2):158–74.CrossRefPubMed
18.
Langer O et al. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med. 2000;343(16):1134–8.CrossRefPubMed
19.
Langer O et al. Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome. Am J Obstet Gynecol. 2005;192(1):134–9.CrossRefPubMed
20.
Kremer CJ, Duff P. Glyburide for the treatment of gestational diabetes. Am J Obstet Gynecol. 2004;190:1438–9.CrossRefPubMed
21.
Franz MJ, Evert A. American Diabetes Association guide to nutrition therapy for diabetes. 2nd ed. Alexandria, VA: American Diabetes Association; 2012.
22.
The American College of Obstetricians and Gynecologists. Exercise during pregnancy and the postpartum period: ACOG committee opinion number 267. Washington, DC: The American College of Obstetricians and Gynecologists; 2002.
23.
Harris GD, White RD. Diabetes management and exercise in pregnant patients with diabetes. Clinical Diabetes. 2005;23:165–8.CrossRef
24.
Tomar AS et al. Intrauterine programming of diabetes and obesity. Curr Obes Rep. 2015;4(4):418–28.CrossRefPubMed
25.
Barua S, Junaid MA. Lifestyle, pregnancy and epigenetic effects. Epigenomics. 2015;7(1):85–102.CrossRefPubMed
26.
Eriksson JG. Epidemiology, genes and the environment: lessons learned from the Helsinki Birth Cohort Study. J Intern Med. 2007;261(5):418–25.CrossRefPubMed
27.
Calkins K, Devaskar SU. Fetal origins of adult disease. Curr Probl Pediatr Adolesc Health Care. 2011;41(6):158–76.CrossRefPubMedPubMedCentral
28.
Moisiadis VG, Matthews SG. Glucocorticoids and fetal programming part 1: outcomes. Nat Rev Endocrinol. 2014;10:391–402.CrossRefPubMed
29.
Moisiadis VG, Matthews SG. Glucocorticoids and fetal programming part 2: mechanisms. Nat Rev Endocrinol. 2014;10:403–11.CrossRefPubMed
30.
Pedersen J, Osler M. Hyperglycemia as the cause of characteristic feature of the foetus and newborn of diabetic mothers. Dan Med Bull. 1961;8:78–83.PubMed
31.
Freinkel N. Of pregnancy and progeny. Diabetes. 1980;29:1023–35.CrossRefPubMed
32.
Hales CN et al. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ. 1991;303:1019–22.CrossRefPubMedPubMedCentral
33.
McCance DR et al. Birth weight and non-insulin dependent diabetes: thrifty genotype, thrifty phenotype, or surviving small baby genotype? BMJ. 1994;308(6934):942–5.CrossRefPubMedPubMedCentral
34.
Whincup PH et al. Birth weight and risk of type 2 diabetes: a systematic review. JAMA. 2008;300(24):2886–97.CrossRefPubMed
35.
Uribarri J et al. Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1. Diabetes Care. 2011;34(7):1610–6.CrossRefPubMedPubMedCentral
36.
Tang Z et al. Placental Hofbauer cells and complications of pregnancy. Ann NY Acad Sci. 2011;1221:103–8.CrossRefPubMedPubMedCentral
37.
Clausen TD et al. High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care. 2008;31(2):340–6.CrossRefPubMed
38.
HAPO Study Cooperative Research Group et al. Hypertensive and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991–2002.CrossRef
39.
Pettitt DJ et al. Maternal glucose at 28 weeks of gestation is not associated with obesity in 2-year-old offspring: the Belfast Hyperglycemia and Adverse Pregnancy Outcome (HAPO) family study. Diabetes Care. 2010;33(6):1219–23.CrossRefPubMedPubMedCentral
40.
Lindsay RS et al. Programming of adiposity in offspring of mothers with type 1 diabetes at age 7 years. Diabetes Care. 2010;33:1080–5.CrossRefPubMedPubMedCentral
41.
Gillman MW et al. Effect of treatment of gestational diabetes on obesity in the next generation. Diabetes Care. 2010;33:964–8.CrossRefPubMedPubMedCentral
42.
Pirkola J et al. Risks of overweight and abdominal obesity at age 16 years associated with prenatal exposures to maternal prepregnancy overweight and gestational diabetes mellitus. Diabetes Care. 2010;33(5):1115–21.CrossRefPubMedPubMedCentral

Be confident that your patient care is up to date

Medicine Matters is being incorporated into Springer Medicine, our new medical education platform. 

Alongside the news coverage and expert commentary you have come to expect from Medicine Matters diabetes, Springer Medicine's complimentary membership also provides access to articles from renowned journals and a broad range of Continuing Medical Education programs. Create your free account »